Literature DB >> 31004024

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group.

Elizabeth A Raetz1, Mignon L Loh2, Meenakshi Devidas3, Kelly Maloney4, Leonard A Mattano5, Eric Larsen6, Andrew Carroll7, Nyla A Heerema8, Julie M Gastier-Foster9, Brent Wood10, Michael J Borowitz11, Naomi Winick12, Stephen P Hunger13, William L Carroll14.   

Abstract

Entities:  

Year:  2019        PMID： 31004024      PMCID： PMC6821605          DOI： 10.3324/haematol.2018.215616

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

Authors:  Kirk R Schultz; D Jeanette Pullen; Harland N Sather; Jonathan J Shuster; Meenakshi Devidas; Michael J Borowitz; Andrew J Carroll; Nyla A Heerema; Jeffrey E Rubnitz; Mignon L Loh; Elizabeth A Raetz; Naomi J Winick; Stephen P Hunger; William L Carroll; Paul S Gaynon; Bruce M Camitta
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

Review 2.  Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies.

Authors:  P A Moalli; S T Rosen
Journal:  Leuk Lymphoma       Date:  1994-11

3.  Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

Authors:  A Möricke; M Zimmermann; A Reiter; G Henze; A Schrauder; H Gadner; W D Ludwig; J Ritter; J Harbott; G Mann; T Klingebiel; F Zintl; C Niemeyer; B Kremens; F Niggli; D Niethammer; K Welte; M Stanulla; E Odenwald; H Riehm; M Schrappe
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

4.  [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)].

Authors:  H Riehm; A Reiter; M Schrappe; F Berthold; R Dopfer; V Gerein; R Ludwig; J Ritter; B Stollmann; G Henze
Journal:  Klin Padiatr       Date:  1987 May-Jun       Impact factor: 1.349

5.  The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia.

Authors:  T Révész; G Kardos; P Kajtár; D Schuler
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

6.  Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.

Authors:  Eric C Larsen; Meenakshi Devidas; Si Chen; Wanda L Salzer; Elizabeth A Raetz; Mignon L Loh; Leonard A Mattano; Catherine Cole; Alisa Eicher; Maureen Haugan; Mark Sorenson; Nyla A Heerema; Andrew A Carroll; Julie M Gastier-Foster; Michael J Borowitz; Brent L Wood; Cheryl L Willman; Naomi J Winick; Stephen P Hunger; William L Carroll
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

7.  Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.

Authors:  Andrew E Place; Kristen E Stevenson; Lynda M Vrooman; Marian H Harris; Sarah K Hunt; Jane E O'Brien; Jeffrey G Supko; Barbara L Asselin; Uma H Athale; Luis A Clavell; Peter D Cole; Kara M Kelly; Caroline Laverdiere; Jean-Marie Leclerc; Bruno Michon; Marshall A Schorin; Jennifer J G Welch; Steven E Lipshultz; Jeffery L Kutok; Traci M Blonquist; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman
Journal:  Lancet Oncol       Date:  2015-11-06       Impact factor: 41.316

8.  Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia.

Authors:  C H Pui; D Pei; J T Sandlund; R C Ribeiro; J E Rubnitz; S C Raimondi; M Onciu; D Campana; L E Kun; S Jeha; C Cheng; S C Howard; M L Metzger; D Bhojwani; J R Downing; W E Evans; M V Relling
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

9.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

10.  Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.

Authors:  W L Salzer; M Devidas; W L Carroll; N Winick; J Pullen; S P Hunger; B A Camitta
Journal:  Leukemia       Date:  2009-12-17       Impact factor: 11.528
View more
  1 in total

1.  Multi-omics analysis reveals the genetics and immune landscape of dexamethasone responsive genes in cancer microenvironment.

Authors:  Yu Shen; Ying C Wu; Lixiong Gu
Journal:  Ann Transl Med       Date:  2020-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.